Literature DB >> 28602709

Factors associated with the use of potentially inappropriate medications by older adults with cancer.

Cristiane Moreira Reis1, Andrezza Gouvêa Dos Santos2, Paula de Jesus Souza2, Adriano Max Moreira Reis3.   

Abstract

OBJECTIVES: To determine the frequency and the factors associated with the use of potentially inappropriate medications (PIMs) by older adults with cancer at an onco-haematology ambulatory clinic of a teaching hospital in Brazil.
MATERIAL AND METHODS: Patients aged 60years or older (n=160) subjected to parenteral antineoplastic chemotherapy from May to December 2015 and treated with one or more medications in the ambulatory clinic were interviewed. Data on medications, comorbidities, oncological diagnosis, and functional status were recorded. Functionality was determined using the Vulnerable Elders Survey (VES-13). PIMs were determined using the 2015 Beers Criteria. Logistic regression was used to determine the factors associated with the use of PIMs.
RESULTS: A total of 78 (48.1%) older adults used at least one PIM. The PIMs to be avoided by older adults were proton pump inhibitors (33.3%), antiemetics (10.5%), long-acting benzodiazepines (10.5%), and antidepressants (7.6%). Multivariate analysis indicated that PIMs were associated with the use of five or more medications (odds ratio, 3.14; 95% confidence interval, 1.4-6.6), after adjusting for the number of medications, number of comorbidities, depression, and arthritis/arthrosis.
CONCLUSION: The frequency of use of PIMs by older adults at the investigated ambulatory clinic was high. Polypharmacy was positively associated with the use of PIMs.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aged; Drug therapy; Inappropriate prescribing; Neoplasm; Oncology; Potentially inappropriate medication list

Mesh:

Year:  2017        PMID: 28602709     DOI: 10.1016/j.jgo.2017.05.003

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


  8 in total

1.  Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.

Authors:  Soojung Hong; Ju Hyun Lee; Eun Kyeong Chun; Kwang-Il Kim; Jin Won Kim; Se Hyun Kim; Yun-Gyoo Lee; In Gyu Hwang; Jin Young Kim; Su-Jin Koh; Yoon Ho Ko; Seong Hoon Shin; In Sook Woo; Tae-Yong Kim; Ji Yeon Baek; Hyun Jung Kim; Hyo Jung Kim; Myung Ah Lee; Jung Hye Kwon; Yong Sang Hong; Hun-Mo Ryoo; Jee Hyun Kim
Journal:  Oncologist       Date:  2019-11-27

2.  Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.

Authors:  Soojung Hong; Ju Hyun Lee; Eun Kyeong Chun; Kwang-Il Kim; Jin Won Kim; Se Hyun Kim; Yun-Gyoo Lee; In Gyu Hwang; Jin Young Kim; Su-Jin Koh; Yoon Ho Ko; Seong Hoon Shin; In Sook Woo; Tae-Yong Kim; Ji Yeon Baek; Hyun Jung Kim; Hyo Jung Kim; Myung Ah Lee; Jung Hye Kwon; Yong Sang Hong; Hun-Mo Ryoo; Jee Hyun Kim
Journal:  Oncologist       Date:  2019-11-27

3.  Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy.

Authors:  Grace Lu-Yao; Ginah Nightingale; Nikita Nikita; Scott Keith; Krupa Gandhi; Kristine Swartz; Ralph Zinner; Swapnil Sharma; W M Kevin Kelly; Andrew Chapman
Journal:  J Geriatr Oncol       Date:  2020-03-19       Impact factor: 3.599

4.  Pilot Randomized Trial of a Pharmacy Intervention for Older Adults with Cancer.

Authors:  Ryan D Nipp; Margaret Ruddy; Charn-Xin Fuh; Mark L Zangardi; Christine Chio; E Bridget Kim; Barbara Kong Mui Li; Ying Long; Gayle C Blouin; Daniel Lage; David P Ryan; Joseph A Greer; Areej El-Jawahri; Jennifer S Temel
Journal:  Oncologist       Date:  2018-10-19

5.  Discontinuation of medications at the end of life: A population study in Belgium, based on linked administrative databases.

Authors:  Kristel Paque; Robrecht De Schreye; Monique Elseviers; Robert Vander Stichele; Koen Pardon; Tinne Dilles; Thierry Christiaens; Luc Deliens; Joachim Cohen
Journal:  Br J Clin Pharmacol       Date:  2019-02-22       Impact factor: 4.335

6.  Optimising pharmacotherapy in older cancer patients with polypharmacy.

Authors:  Elze Vrijkorte; Jennifer de Vries; Ron Schaafsma; Machteld Wymenga; Thijs Oude Munnink
Journal:  Eur J Cancer Care (Engl)       Date:  2019-11-06       Impact factor: 2.520

7.  Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicity.

Authors:  Yon-Dschun Ko; Andreas H Jacobs; Ulrich Jaehde; Imke Ortland; Monique Mendel Ott; Michael Kowar; Christoph Sippel
Journal:  BMC Geriatr       Date:  2022-08-30       Impact factor: 4.070

8.  A systematic review of rehabilitation and exercise recommendations in oncology guidelines.

Authors:  Nicole L Stout; Daniel Santa Mina; Kathleen D Lyons; Karen Robb; Julie K Silver
Journal:  CA Cancer J Clin       Date:  2020-10-27       Impact factor: 508.702

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.